A032980 Stock Overview
BYON Co., Ltd. manufactures and sells industrial chemicals in South Korea and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
BYON Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩936.00 |
| 52 Week High | ₩2,135.00 |
| 52 Week Low | ₩723.00 |
| Beta | 0.98 |
| 1 Month Change | 1.08% |
| 3 Month Change | -14.13% |
| 1 Year Change | -30.67% |
| 3 Year Change | -66.21% |
| 5 Year Change | -69.61% |
| Change since IPO | -99.93% |
Recent News & Updates
Recent updates
Some Confidence Is Lacking In BYON Co., Ltd.'s (KOSDAQ:032980) P/S
Mar 20
Calculating The Intrinsic Value Of BYON Co., Ltd. (KOSDAQ:032980)
Apr 09BYON's (KOSDAQ:032980) Shareholders Are Down 37% On Their Shares
Mar 05Is BYON (KOSDAQ:032980) Using Too Much Debt?
Jan 11If You Had Bought BYON (KOSDAQ:032980) Stock A Year Ago, You Could Pocket A 20% Gain Today
Nov 19
Shareholder Returns
| A032980 | KR Chemicals | KR Market | |
|---|---|---|---|
| 7D | 20.9% | -0.07% | 0.5% |
| 1Y | -30.7% | -28.0% | 4.7% |
Return vs Industry: A032980 underperformed the KR Chemicals industry which returned -28% over the past year.
Return vs Market: A032980 underperformed the KR Market which returned 4.7% over the past year.
Price Volatility
| A032980 volatility | |
|---|---|
| A032980 Average Weekly Movement | 9.2% |
| Chemicals Industry Average Movement | 4.8% |
| Market Average Movement | 5.3% |
| 10% most volatile stocks in KR Market | 11.8% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A032980's share price has been volatile over the past 3 months.
Volatility Over Time: A032980's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1983 | 14 | Seong-Min Lee | www.by-on.co.kr |
BYON Co., Ltd. manufactures and sells industrial chemicals in South Korea and internationally. The company engages in the development of cell therapy using stem cell technology and commercialization of myocardial cells. The company also provides health functional food ingredients for pharmaceutical and food companies.
BYON Co., Ltd. Fundamentals Summary
| A032980 fundamental statistics | |
|---|---|
| Market cap | ₩37.91b |
| Earnings (TTM) | -₩6.98b |
| Revenue (TTM) | ₩8.89b |
4.3x
P/S Ratio-5.4x
P/E RatioIs A032980 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A032980 income statement (TTM) | |
|---|---|
| Revenue | ₩8.89b |
| Cost of Revenue | ₩6.84b |
| Gross Profit | ₩2.05b |
| Other Expenses | ₩9.03b |
| Earnings | -₩6.98b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -172.26 |
| Gross Margin | 23.11% |
| Net Profit Margin | -78.50% |
| Debt/Equity Ratio | 19.5% |
How did A032980 perform over the long term?
See historical performance and comparison